EODData

FRA, 2QV0: CHEMOMAB THERAP. ADR/20

20 Oct 2025
LAST:

2.940

CHANGE:
 0.00
OPEN:
2.940
HIGH:
2.940
ASK:
0.000
VOLUME:
0
CHG(%):
0.00
PREV:
2.940
LOW:
2.940
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

COMPANY PROFILE

Name:CHEMOMAB THERAP. ADR/20
About:Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
Sector:Healthcare
Industry:Biotechnology
Address:Building 7, Tel Aviv, Israel, 6158002
Website:https://www.chemomab.com
ISIN:US16385C1045

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.85 
Forward P/E:-18.38 
PEG Ratio:-0.04 
Price to Book:0.39 
Return on Assets:-0.62 
Return on Equity:-1.20 
Shares:20.76M 
Market Cap:61.05M 

TECHNICAL INDICATORS

MA5:2.940.0%
MA10:2.940.0%
MA20:2.1834.9%
MA50:1.42107.0%
MA100:1.26133.9%
MA200:1.38112.4%
STO14:100.00 
MTM14:2.21
ROC14:3.00 
ATR:0.16 
Week High:2.940.0%
Week Low:2.940.0%
Month High:2.940.0%
Month Low:2.94112.4%
Year High:2.940.0%
Year Low:0.72311.2%
Volatility:350.30 

RECENT SPLITS

Date Ratio
26 Aug 20251-4